Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis

AIMS: Due to its high heterogenicity and unclear etiology, there is currently no specific treatment for polycystic ovary syndrome (PCOS). Metformin, as an insulin sensitizer, combined with spironolactone, an antiandrogen medication, may exert complementary effects on PCOS. We therefore performed a m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Huamin, Zhang, Ying, Huang, Sikai, Wu, Jinghua, Ren, Wenrui, Zhou, Lingru, Huang, Leneng, Ye, Yuyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449574/
https://www.ncbi.nlm.nih.gov/pubmed/37635987
http://dx.doi.org/10.3389/fendo.2023.1223768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449574/
https://www.ncbi.nlm.nih.gov/pubmed/37635987
http://dx.doi.org/10.3389/fendo.2023.1223768

Ejemplares similares